Breast cancer cryoablation in combination with anti-CTLA-4 increases T cell activation in a murine tumor model

被引：0
|
作者：
de Miranda, Flavia Sardela [1 ]
Babcock, Rachel [1 ]
Castro, Maribel [1 ]
Khan, Sonia Y. [1 ]
Roach, Carsen [2 ]
Hintelmann, Thomas [1 ]
Furr, Kathryn [1 ]
Lee, Chang H. [2 ]
Boligala, Geetha P. [1 ]
Rasha, Fahmida [1 ]
Brandi, Luis [1 ]
Gill, Harvinder S. [2 ]
Pruitt, Kevin [1 ]
Rahman, Rakhshanda L. [1 ]
机构：
[1] Texas Tech Univ Hlth Sci Ctr, Lubbock, TX USA
[2] Texas Tech Univ, Lubbock, TX USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2022年 / 10卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B18
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effects of anti-ctla-4 and anti-pd-1 on memory T-cell differentiation and resistance to tumor relapse
    Mok, Stephen
    Duffy, Colm R.
    Allison, James P.
    CANCER RESEARCH, 2017, 77
  • [22] Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse
    Mok, Stephen
    Duffy, Colm R.
    Anang, Nana-Ama A. S.
    Allison, James P.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [23] Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse
    Mok, Stephen
    Duffy, Colm R.
    Allison, James P.
    CANCER RESEARCH, 2018, 78 (13)
  • [24] Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response
    Rupp, Tristan
    Genest, Laurie
    Babin, David
    Legrand, Christophe
    Hunault, Marion
    Froget, Guillaume
    Castagne, Vincent
    TRANSLATIONAL ONCOLOGY, 2022, 20
  • [25] Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse
    Mok, Stephen
    Duffy, Colm R.
    Allison, James P.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [26] Immunophenotypic and transcriptome analyses of CT26 and 4T1 murine tumor models following anti-CTLA-4 treatment
    Barnes, Sheri R.
    Draper, David
    Church, Sarah E.
    Franklin, Maryland Rosenfeld
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapy
    Sznol, M.
    Melero, I.
    ANNALS OF ONCOLOGY, 2021, 32 (03) : 295 - 297
  • [28] Combination Cancer Immunotherapy with Molecular Targeted Agents/Anti-CTLA-4 Antibody for Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2019, 8 (01) : 1 - 11
  • [29] Effect of anti-CTLA-4 antibody treatment on T-cell repertoire evolution in treated cancer patients
    Cha, Edward
    Hou, Yafei
    Klinger, Mark
    Cummings, Craig
    Faham, Malek
    Ribas, Antoni
    Fong, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Antitumor activity of anti-CTLA-4 monoclonal antibody (mAb) in combination with ixabepilone in preclinical tumor models
    Jure-Kunkel, M. N.
    Masters, G.
    Girit, E.
    Dito, G.
    Lee, F. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345